Now it’s laying out an array of funding opportunities worth billions of dollars to researchers and innovators.
Investments of $1.69 billion are supporting clinical trials, advanced development of therapeutics, rapid vaccine development and diagnostics as well as expansion of US-based production of medical countermeasures.
The National Science Foundation turbo-charged its Rapid Response Research (RAPID) funding mechanism, which allows the agency to fast-track grants up to $200,000 for urgent COVID-19 research research proposals.
In recent weeks, NSF has granted 58 awards for RAPID research funding.
NSF is also offering funding opportunities for small businesses that are developing new technologies, products, and services with potential to assist in coronavirus response.

Comments to: Federal agencies are setting aside billions for coronavirus research: Here’s a list

Your email address will not be published. Required fields are marked *

Attach images - Only PNG, JPG, JPEG and GIF are supported.


Welcome to Typer

Brief and amiable onboarding is the first thing a new user sees in the theme.
Join Typer
Registration is closed.